BFB Health (0205) has a market capitalization of approximately HK$813M, trading at HK$0.65 on the HKSE. Market cap moves with the live share price.
BFB Health's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Communication Services sector peers rather than read in isolation.
BFB Health runs a net profit margin of -16.7%, a gross margin of 49.0%, and an operating margin of -47.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
BFB Health reported revenue of HK
BFB Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
BFB Health carries a debt-to-equity ratio of 0.11x and a current ratio of 2.11x, with a market beta of 0.87. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For BFB Health (0205) the key facts are: market cap HK$813M, revenue HK
Get BFB Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.